MarketPeel
Insider Trading Intelligence
MP

Myrtle S. Potter

DNA
DIRECTOR · GINKGO BIOWORKS HOLDINGS, INC. · CIK 0001214130
FILING MIX · LIFETIME53%/47%
BUYS
56
SELLS
49
TOTAL VALUE
$341.9K
COMPANIES
2
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
20,971
AVG SELL PX
$79.28
TRADE KIND
SHOWING 105 / 105
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 10 pending
Forward-return performance of every backtestable P/S trade by Myrtle S. Potter, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%+2.12%+0.88%+1.24%-0.28%
14d6+33.33%+9.45%+1.86%+7.59%+5.59%
30d6+33.33%+12.60%+2.59%+10.01%+5.28%
60d6+0.00%+31.02%+4.45%+26.58%+11.66%
90d6+0.00%+44.52%+6.21%+38.31%+45.27%
180d6+0.00%+82.87%+8.49%+74.38%+80.77%
1y6(4 pending)+0.00%+160.02%+24.63%+135.39%+135.39%
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DNA · 0 shares · as of Jun 11, 2025
0277,778555,556833,3331,111,1112025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 56 buys / 49 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
1,556$131.16$204.1K20,971Jun 22, 2026Jun 23, 2026View →
GH
GUARDANT HEALTH, INC.
PURCHASE
4,20322,527Jun 17, 2026Jun 22, 2026View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
2,7112,711Jun 17, 2026Jun 22, 2026View →
GH
GUARDANT HEALTH, INC.
SALE
4,2030Jun 17, 2026Jun 22, 2026View →
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
26$66.95$1.7K18,324Oct 17, 2025Oct 20, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6918,350Oct 15, 2025Oct 16, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
690Oct 15, 2025Oct 16, 2025View →
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
26$55.63$1.4K18,281Sep 17, 2025Sep 17, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6818,307Sep 15, 2025Sep 17, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
6869Sep 15, 2025Sep 17, 2025View →
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
26$59.02$1.5K18,239Aug 19, 2025Aug 20, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
69137Aug 15, 2025Aug 18, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6918,265Aug 15, 2025Aug 18, 2025View →
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
26$48.20$1.3K18,196Jul 17, 2025Jul 18, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
68206Jul 15, 2025Jul 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6818,222Jul 15, 2025Jul 16, 2025View →
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
26$49.47$1.3K18,154Jun 18, 2025Jun 20, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
4,2034,203Jun 18, 2025Jun 20, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
6,8336,833Jun 18, 2025Jun 20, 2025View →
GH
GUARDANT HEALTH, INC.
SALE10b5-1
10b5-1 plan
2,626$49.70$130.5K18,180Jun 16, 2025Jun 16, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
69274Jun 15, 2025Jun 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6920,806Jun 15, 2025Jun 16, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
6,6740Jun 12, 2025Jun 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6,67420,737Jun 12, 2025Jun 16, 2025View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
PURCHASE
10,82210,822Jun 11, 2025Jun 13, 2025View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
SALE
10,8220Jun 11, 2025Jun 13, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
68343May 15, 2025May 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6814,063May 15, 2025May 16, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
68411Apr 15, 2025Apr 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,995Apr 15, 2025Apr 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6913,927Mar 15, 2025Mar 18, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
69479Mar 15, 2025Mar 18, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,858Feb 15, 2025Feb 18, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
68548Feb 15, 2025Feb 18, 2025View →
GH
GUARDANT HEALTH, INC.
SALE
68616Jan 15, 2025Jan 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,790Jan 15, 2025Jan 16, 2025View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6913,722Dec 15, 2024Dec 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
69684Dec 15, 2024Dec 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,653Nov 15, 2024Nov 18, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
68753Nov 15, 2024Nov 18, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
69821Oct 15, 2024Oct 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6913,585Oct 15, 2024Oct 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,516Sep 15, 2024Sep 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
68890Sep 15, 2024Sep 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
68958Aug 15, 2024Aug 19, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,448Aug 15, 2024Aug 19, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6913,380Jul 15, 2024Jul 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
691,026Jul 15, 2024Jul 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
6813,311Jun 15, 2024Jun 17, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
681,095Jun 15, 2024Jun 17, 2024View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
432,900432,900Jun 13, 2024Jun 14, 2024View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
571,428571,428Jun 13, 2024Jun 14, 2024View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,111,1111,111,111Jun 13, 2024Jun 14, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
5,5920Jun 12, 2024Jun 13, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
10,70310,703Jun 12, 2024Jun 13, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
5,59213,243Jun 12, 2024Jun 13, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
6,6746,674Jun 12, 2024Jun 13, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
691,163May 15, 2024May 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
697,651May 15, 2024May 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
687,582Apr 15, 2024Apr 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
681,232Apr 15, 2024Apr 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
681,300Mar 15, 2024Mar 18, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
687,514Mar 15, 2024Mar 18, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
691,368Feb 15, 2024Feb 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
697,446Feb 15, 2024Feb 16, 2024View →
GH
GUARDANT HEALTH, INC.
SALE
681,437Jan 15, 2024Jan 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
687,377Jan 15, 2024Jan 16, 2024View →
GH
GUARDANT HEALTH, INC.
PURCHASE
697,309Dec 15, 2023Dec 18, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
691,505Dec 15, 2023Dec 18, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
681,574Nov 15, 2023Nov 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
687,240Nov 15, 2023Nov 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
687,172Oct 15, 2023Oct 16, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
681,642Oct 15, 2023Oct 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
697,104Sep 15, 2023Sep 19, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
691,710Sep 15, 2023Sep 19, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
681,779Aug 15, 2023Aug 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
687,035Aug 15, 2023Aug 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
696,967Jul 15, 2023Jul 17, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
691,847Jul 15, 2023Jul 17, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
686,898Jun 15, 2023Jun 16, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
681,916Jun 15, 2023Jun 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
5,5316,830Jun 14, 2023Jun 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
5,5925,592Jun 14, 2023Jun 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
8,8038,803Jun 14, 2023Jun 16, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
5,5310Jun 14, 2023Jun 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
681,299May 15, 2023May 16, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
681,984May 15, 2023May 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
691,231Apr 15, 2023Apr 17, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
692,052Apr 15, 2023Apr 17, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
681,162Mar 15, 2023Mar 16, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
682,121Mar 15, 2023Mar 16, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
692,189Feb 15, 2023Feb 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
691,094Feb 15, 2023Feb 16, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
681,025Jan 15, 2023Jan 17, 2023View →
GH
GUARDANT HEALTH, INC.
SALE
682,258Jan 15, 2023Jan 17, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
68957Dec 15, 2022Dec 20, 2022View →
GH
GUARDANT HEALTH, INC.
SALE
682,326Dec 15, 2022Dec 20, 2022View →
GH
GUARDANT HEALTH, INC.
SALE
692,394Nov 15, 2022Nov 16, 2022View →
GH
GUARDANT HEALTH, INC.
PURCHASE
69889Nov 15, 2022Nov 16, 2022View →
GH
GUARDANT HEALTH, INC.
SALE
8202,463Oct 15, 2022Oct 18, 2022View →
GH
GUARDANT HEALTH, INC.
PURCHASE
820820Oct 15, 2022Oct 18, 2022View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
8,7898,789Jun 15, 2022Jun 17, 2022View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
5,5315,531Jun 15, 2022Jun 17, 2022View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
3,2833,283Nov 8, 2021Nov 10, 2021View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
5,6135,613Nov 8, 2021Nov 10, 2021View →
Other insiders · DNA
Loading peer insiders…
About this filer
CIK 0001214130
ROLE
Director
PRIMARY
DNA
COMPANIES
2
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001214130DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback